A Chicago jury this week jury ruled in favor of healthcare giant Johnson & Johnson (NYSE:JNJ), rejecting a patient’s claims that the company was liable for injuries she allegedly sustained after receiving the metal-on-metal ASR XL hip implant.
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
Layoffs ahead for Medtronic’s spinal business
Stryker’s knee surgery device recall gets FDA’s highest-risk label
Biomet CEO (and blogger) Jeff Binder takes a strong stand on gain-sharing
Two decades after he jumped ship from the Boston Consulting Group into the orthopedic world, the business of bones and joints still fascinates Jeff Binder, despite some of the headwinds the industry has faced over the past 5 years.
Maybe that’s because the CEO of Warsaw, Ind.-based Biomet, a privately held orthopedic medical device company, is experienced enough to know the industry has been counted out before.
FDA reschedules orthopedic panel meeting
The FDA rescheduled a meeting of its Orthopedic & Rehabilitation Devices Panel, originally slated for April 5, to discuss reclassifying shortwave diathermy devices and pedicle screws.
The shortwave diathermy meeting is now scheduled for May 21 in Gaithersburg, Md., the agency said.
Biomet losses continue to expand amid growing sales
Orthopedic devices maker and market bellwether Biomet this week posted strong 3rd quarter revenue growth, with a boost in sales in the U.S. and abroad and a new trauma acquisition performing admirably, but losses continued to widen for the Warsaw, Ind.-based medical device company.
UPDATE: Details on ex-Denstply CFO Ellison’s jump to Stryker
Dentsply International (NSDQ:XRAY) detailed its plans to replace ex-CFO William Jellison, who jumped ship today for medical device company Stryker (NYSE:SYK).
FLASH: Stryker nabs Dentsply CFO Jellison
Medical device company Stryker (NYSE:SYK) said it hired William Jellison, the finance chief for Dentsply International (NSDQ:XRAY), to be its new CFO.
Former FDA official testifies on behalf of DePuy in metal hip implant lawsuit
A former FDA official told jurors this week that Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics followed proper federal guidelines in monitoring its now-recalled metal-on-metal hip implants.
FDA postpones orthopedic devices panel on shortwave diathermy devices
The FDA’s Orthopaedic & Rehabilitation Devices Panel postponed today’s meeting over scheduling conflicts that meant key players couldn’t attend.
The meeting was convened to discuss a possible reclassification of shortwave diathermy devices, which are used to therapeutically heat tissue with an electric current with applications in joint inflammation treatments and physiotherapy.
InVivo Therapeutics’ spinal cord scaffold wins FDA nod
InVivo Therapeutics (OTC:NVIV) said the FDA deemed its biopolymer scaffold, designed to treat spinal cord injuries, to be a humanitarian use device.
The designation means the InVivo scaffold can seek expedited approval from the FDA for a pivotal trial of the device. HUD-based exemptions cover devices aimed at treating rare diseases and health problems, so-called "orphan" conditions.